Plandaí Biotechnology, Inc. (PLPL)
OTCMKTS · Delayed Price · Currency is USD
0.00001
0.00 (0.00%)
Jul 24, 2026, 9:30 AM EST

Plandaí Biotechnology Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2016FY 2015FY 2014FY 2013FY 2012
Period EndingSep '16 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Revenue
0.340.30.090.270.360.07
Revenue Growth
215.33%221.31%-65.04%-26.01%382.38%-
Gross Profit
-0.57-0.64-0.69-0.69-0.60.07
Operating Income
-2.95-3.11-8.85-4.74-2.66-3.81
Net Income
-4.32-4.38-9.58-15.61-2.19-3.78
Earnings Per Share
-0.02-0.03-0.07-0.14-0.02-0.04
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2016FY 2015FY 2014FY 2013FY 2012
Period EndingSep '16 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Cash & Investments
0.020.010.030.160.50.01
Total Debt
16.8315.8116.0413.111.526.84
Net Cash (Debt)
-16.81-15.8-16.01-12.95-11.02-6.83
Net Cash Growth
------
Net Cash Per Share
-0.09-0.09-0.12-0.11-0.10-0.07

Cash Flow & CapEx

Fiscal YearTTMFY 2016FY 2015FY 2014FY 2013FY 2012
Period EndingSep '16 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Operating Cash Flow
-0.94-1.07-2.7-2.83-1.78-0.8
Capital Expenditures
-0.06-0.01-0.86-0.49-2.03-6.03
Free Cash Flow
-1-1.08-3.56-3.32-3.81-6.83
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2016FY 2015FY 2014FY 2013FY 2012
Period EndingSep '16 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Gross Margin
-168.10%-215.98%--257.95%-168.20%100.00%
Operating Margin
-871.19%-1041.50%-9526.11%-1785.27%-740.03%-5117.09%
Pretax Margin
-1377.39%-1588.25%-10842.37%-6038.76%-826.48%-5155.48%
Profit Margin
-1275.88%-1467.07%-10315.03%-5873.14%-609.23%-5073.30%
FCF Margin
-295.30%-362.92%-3833.01%-1249.98%-1059.98%-9168.49%

Valuation

Fiscal YearCurrentFY 2016FY 2015FY 2014FY 2013FY 2012
Period EndingJul '26 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
PS Ratio
0.1319.88388.78177.63160.05333.93